|Bid||0.6460 x 900|
|Ask||0.6580 x 1100|
|Day's Range||0.6303 - 0.6471|
|52 Week Range||0.4000 - 1.5000|
|Beta (3Y Monthly)||2.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 25.00% and 50.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Matinas Biopharma Holdings, Inc. (MTNB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you want to know who really controls Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB), then you'll have to look at...
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
If you own shares in Matinas BioPharma Holdings Inc (NYSEMKT:MTNB) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a Read More...